Sale of ICX-TRC
18th March 2010
Regenerative Medicine Assets Limited (formerly Intercytex Group plc) today announces that it has completed the sale of certain assets related to its hair regeneration product ICX-TRC from its wholly owned subsidiary Intercytex Limited to Aderans Research Institute Inc. (an affiliate of Aderans Co Ltd of Japan, and Bosley) for US$200,000.
The Company continues with detailed discussions regarding the sale of its remaining business assets, primarily Vavelta, and anticipates making further announcements in due course.
___
So now we have two big boss's of hair loss together right?
This could be good?
18th March 2010
Regenerative Medicine Assets Limited (formerly Intercytex Group plc) today announces that it has completed the sale of certain assets related to its hair regeneration product ICX-TRC from its wholly owned subsidiary Intercytex Limited to Aderans Research Institute Inc. (an affiliate of Aderans Co Ltd of Japan, and Bosley) for US$200,000.
The Company continues with detailed discussions regarding the sale of its remaining business assets, primarily Vavelta, and anticipates making further announcements in due course.
___
So now we have two big boss's of hair loss together right?
This could be good?
